@article{ATM24995,
author = {Hira Latif and Stephen V. Liu},
title = {Combining immunotherapy and epidermal growth factor receptor kinase inhibitors: worth the risk?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {Immunotherapy has improved survival in advanced non-small cell lung cancer (NSCLC) and offers the potential for meaningful, durable responses in a subset of patients. Ongoing efforts are focused on extending these benefits to more patients.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/24995}
}